Cortecs International Ltd., Centre for Clinical and Basic Research, Osteometer BioTech AS deal

The parties will collaborate on an oral formulation of testosterone using DLVRY's Hepatic Avoidance using Lymphatic Output (HALO) delivery system. DLVRY will supply an oral formulation of testosterone, while Osteometer and CCBR will conduct biological and human studies.

The HALO liver bypass system is designed to enhance absorption of poorly bioavailable drugs and to create sustained release formulations of certain kinds of drugs and transport them into the bloodstream avoiding the liver. ...